Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: CNTO 148
Total 0 results
Nothing found
Sponsors and Collaborators
Mª Victoria Maestre Sanchez
Eurofins Genoma
Aptis Medical
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Alma Lasers Inc.
Everett Meyer
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Neurophth Therapeutics Inc
Hospital Durand, Argentina
RMIT University, Melbourne, Australia
Agency for Science, Technology and Research
GFI
Nacuity Pharmaceuticals, Inc.
ASST Cremona, Cremona
Hospital ASEPEYO Sant Cugat
Kupfer, David J., M.D.
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Apollo Neuroscience, Inc.
Korean Society of Spine Surgery
iCAD
View Full List
Medical Conditions
Treatment Decisions
Chronic Constipation Symptoms
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Recurrent Clear Cell Sarcoma of Soft Tissue
RISS Stage III Plasma Cell Myeloma
Immune-Mediated Inflammatory Disease
Luteal Phase Support
Metachronous Adenoma
Scleredema
Dienogest
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Rheumatoid Arthritis(RA)
Splenic Trauma
Major Liver Surgery
Corneal Cross-Linking
The Strength Properties of the Aorta in Vitro
Disorder of Fluid Balance
Fever
T-LGL Leukemia
Gastric Cancer Stage IIIB-IIIC
View Full List
Drug Interventions
Anticholinergic
MLN2480
Olopatadine
GLPG1837 multiple ascending doses
Intravenous deferiprone
Camptosar
Capecitabine and IMRT (if randomized to this arm)
THC
TPN-101
Standard of care (SOC) for COVID-19
Letrozole
PD-1/PD-L1 inhibitor
OnabotulinumtoxinA
Intravenous Formulation of PD-0332991
Midazolam
Fospropofol disodium, propofol
Capecitabine/cisplatin
Oxycodone/acetaminophen 5/325 mg
Desvenlafaxine
RDX227675
View Full List
CROs by country
Contract Research Organizations in Benin
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Ethiopia
Contract Research Organizations in Greece
Contract Research Organizations in Montenegro
Contract Research Organizations in Philippines
Contract Research Organizations in Romania
Contract Research Organizations in Saudi Arabia
Contract Research Organizations in Spain
Contract Research Organizations in Tanzania
Contract Research Organizations in Tunisia
Contract Research Organizations in Uganda
Contract Research Organizations in United States
CRO list by country
CROs in Bahamas
SGS
All CROs in Bahamas
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe